ESOPHAGEAL CANCER & GASTROESOPHAGEAL JUNCTION CANCER - FDA approved drugs

This report is specific for Esophageal Cancer & Gastroesophageal Junction Cancer. 
This 22 page report has 10 sections, which includes basic explanation of the disease state, 5-year survival rate, basic outline of current therapeutic approaches, information on 16 FDA approved drugs, outline of the mechanism of action for each drug, outcome of clinical trials measured as response rate, median overall survival and disease progression-free survival, ongoing clinical trials, information on support groups and list of other credible resources to support your own research.